Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for general anesthesia induction and maintenance in elective surgery
CTR20190755Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam, sponsored by Hengrui Therapeutics. Started Apr 2019; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on CTR20190755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190755.